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Supplementary information 
Oligomeric state of OppA* 
Crystal structures of substrate-binding proteins (SBPs) have shown that they are 
monomers with one substrate-binding site per molecule (Quiocho & Ledvina, 1996). 
However, recently it was shown that TakP, a SBP from a tripartite ATP-independent 
transporter, is a dimer (Gonin et al, 2007). Moreover, in ATP-binding cassette (ABC) 
transporters containing multiple substrate-binding domains (SBDs) fused to the 
translocator, co-operativity between these domains has been observed (Biemans-
Oldehinkel & Poolman, 2003). Several early experiments also suggested that SBPs 
self-associate to form dimers or higher order oligomers (Rashed et al, 1976; 
Richarme, 1982; Richarme, 1983) which might be a way to regulate their activity 
(Antonov et al, 1976). To determine the oligomeric state of OppA* we performed 
light scattering and equilibrium centrifugation measurements.  
 
Sedimentation equilibrium centrifugation (Fig. S1c) and static light scattering 
experiments (Fig. 1) unambiguously showed that purified OppA* is a monomer. For 
the ligand-free version of OppA*, the measured molecular weights determined by 
equilibrium centrifugation and static light scattering were 68.2 kDa and 65.0 kDa, 
respectively. These values were close to the calculated molecular weight for the 
monomer of 65.1 kDa, based on the amino acid sequence. Addition of the high-
affinity ligand bradykinin did not significantly change the molecular weight 
determined by sedimentation equilibrium centrifugation. Also, the molecular weight 
of OppA* with endogenous ligand bound, determined by light scattering, did not 
differ from that of ligand-free OppA* (Fig. 1). In contrast, the hydrodynamic 
properties of ligand bound and ligand-free OppA* were significantly different, as 
indicated by sedimentation velocity measurements (Fig. S1a), and by the elution 
volumes observed in gel filtration experiments. Consistent with the equilibrium 
centrifugation data, the sedimentation behaviour of OppA* did not change over the 
concentration range tested (0.02 to 1.30 mg/mL), indicating that the protein was 
present as a single-species not undergoing reversible self-association. The average 
sedimentation coefficient (s20,w), however, increased from 4.2 ± 0.1 S in the absence of 
ligand to 4.6 ± 0.2 S upon the addition of a saturating amount of bradykinin (Fig. 
S1b). Moreover, in gel filtration chromatography experiments, ligand-bound OppA* 
migrated more slowly on a size-exclusion column compared to ligand-free OppA* 
(Fig. 1). This hydrodynamic behavior thus indicates that ligand-bound OppA* adopts 
a more compact conformation than the ligand-free protein, consistent with the Venus 
Flytrap mechanism.  
 
Ligand binding to OppA* 
Protein functionality and the removal of endogenous bound substrate were verified by 
monitoring intrinsic protein fluorescence changes upon titration with peptide (Fig. 
S4). The Kd and maximum change in fluorescence (∆ FFmax) were 0.26 µM and 12.3 %, 
which is close to the values of 0.10 µM and 12.6 % that were obtained previously 
(Lanfermeijer et al, 1999).  
Experimental Procedures  
Purification of OppA* 
Expression of OppA* in Lactococcus lactis AMP2/pAMP21 and cell lysis were done 
as previously described (Lanfermeijer et al, 1999), and the soluble fraction was frozen 
in liquid nitrogen and stored at -80ºC. The lysate was thawed, 0.5 mL Ni2+-sepharose 
resin (Amersham Biosciences) was added per 50 mL lysate, and the mixture was 
incubated for 1 h at 4 oC in buffer A (50mM Tris-HCl, 300 mM NaCl, 10% (v/v) 
glycerol, pH 8.0) supplemented with 15 mM imidazole. Subsequently, the resin was 
washed with buffer A containing 40 mM imidazole, for 20 column volumes (CV). In 
case endogenously bound peptides were removed, OppA* was partially unfolded 
while bound to the resin. The following additional wash steps were performed (all in 
buffer A with 15 mM imidazol): 40 CV with 2M Guanidine-HCl (GndHCl), 4 CV 
with 1.5 M GndHCl, 4 CV with 1 M GndHcl, 4 CV with 0.5 M GndHCl and finally 8 
CV with 0 M GndHCl. The protein was eluted with 20 mM Na-MES, pH 6.0, 300 
mM NaCl, 500 mM imidazole, pH 6.0, 2 CV.  For purification of OppA* with 
endogenously bound peptides, the washing steps with Guanidine-HCl were omitted. 
Purified OppA* was concentrated to 0.5 ml in spin concentrators with 30 kDa cut-off 
(Vivaspin with PES membrane Sartorius), and further purified on a Superdex 200 
10/300 GL size exclusion column (Amersham Biosciences) in 20 mM Na-MES, pH 
6.0, 150 mM NaCl. Fractions containing OppA were pooled, concentrated 10-fold, 
and diluted such that the final buffer composition was 10mM Na-MES, pH 6.0, 
10mM NaCl, and finally concentrated again to 11 mg/mL of protein. For co-
crystallization with peptides, the peptide (10 mM stock in milliQ water) was mixed 1 
to 10 with protein solution yielding final concentrations of 10 mg/mL OppA, 1 mM 
peptide, 9 mM Na-MES, pH 6.0 and 9 mM NaCl. 
Fluorescence titration 
Measurements were performed on a Spex Fluorolog 322 fluorescence 
spectrophotometer (Jobin Yvon) at 25°C in a 1 mL stirred cuvette. For fluorescence 
titration experiments, 0.5-1 µM bradykinin stock solutions were used, and solutions of 
bradykinin were added in 1 µL steps. The excitation and emission wavelengths were 
280 and 318, respectively, with slit widths of 1 and 2 nm, respectively. Titrations with 
water in the absence of protein were performed as reference. 
Analytical ultracentrifugation  
Analytical ultracentrifugation experiments were performed in a Beckman Optima XL-
I, using an AN-50 Ti rotor with 2-channel charcoal-filled centerpieces. Sedimentation 
velocity experiments were done at 38,000 rpm and 4°C on sample volumes of 400 µL 
with loading concentrations ranging from 0.020 to 1.300 mg/mL in 25 mM KPi, pH 
6.0, 100 mM KCl, and 10 % (v/v) glycerol (buffer C). Absorbance data were 
collected at 280 and 230 nm in a continuous mode with a radial step size of 0.005 cm 
and 10 min time intervals. Sedimentation equilibrium experiments were performed at 
rotor speeds of 8,000, 10,000, and 12,000 rpm on sample volumes of 100 µL with 
loading concentrations of 0.020, 0.050, and 0.100 mg/mL OppA in buffer C. The 
absorbance optics was used to collect data every 0.001 cm with 10 replicates at 280 
nm. 
Data analysis was done using the XL-I data analysis software (Beckman). The 
molecular weight of OppA* was determined from the sedimentation equilibrium 
experiments by global fitting of nine data sets. The partial specific volume (θ ) of 
OppA was 0.7227 mL/mg at 4ºC as calculated from the primary amino acid sequence 
using SEDNTERP (developed by Hayes, Laue, and Philo, and available at 
www.jphilo.mailway.com). Values for the solvent density (ρ ) and viscosity (η ) of the η
buffer C were determined using the same program and were 1.03878 g/L and 2.2348 
× 10-2 Poise, respectively, at 4°C. 
Molecular dynamics simulations 
Molecular dynamics simulations were performed with a coarse-grain representation of 
the system using the recently parameterized MARTINI force-field (Marrink et al, 
2007; Monticelli et al, 2008). In the force-field small groups of atoms  (usually 4 
heavy atoms) are united into a single interacting bead. The force-field was 
systematically parameterized on the partitioning free energies of many chemical 
compounds (including the partitioning of amino-acids between polar and apolar 
phases). The force-field has been shown to represent well the protein structure and 
function (Periole et al, 2007; Treptow et al, 2008; Yefimov et al, 2008). The protein 
in the open-state was mapped to its coarse-grain representation from the crystal 
structure. The octamer peptide (RDMPIQAF) was modeled based on the visible 
hexamer densities. The simulation box included 15,000 coarse-grain water beads. 
Simulations were performed using the GROMACS program package (Spoel et al, 
2005), with the scheme developed for coarse-grain simulations, under periodic 
boundary conditions. The temperature was weakly coupled (coupling time 0.1 ps) to a 
thermostat at T = 300K using a Berendsen algorithm (Berendsen et al, 1984). The 
pressure was also weakly coupled at 1 bar (coupling time 1.0 ps, compressibility 5 × 
10-6 bar-1) using an isotropic coupling scheme (Berendsen et al, 1984). The non-
bonded interactions were treated with a switch function from 0.0 to 1.2 nm for the 
Coulomb interactions and 0.9 to 1.2 nm for the LJ interactions (pair-list update 
frequency of once per 10 steps). A time step of 25 fs was used. When interpreting the 
simulation results with the coarse-grain model, a conversion factor of 4 is used, which 
is the effective speed-up factor in the diffusion dynamics of the coarse-grain water 
compared to real water (Marrink et al, 2007; Monticelli et al, 2008).  Six simulations 
with a total simulation time (effective time) of 18 µs were performed. 
 
Miscellaneous  
Protein concentrations were determined accordingly (Lowry et al, 1951), using 
bovine serum albumin as a standard. The concentration of purified OppA was 
determined spectrophotometrically by measuring the absorption at 280 nm and using 
an extinction coefficient of 1.605 (mg/mL)-1 cm-1. Illustrations were produced in 
PyMol (DeLano, 2002). 
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Oligomeric state of OppA*. a) Velocity sedimentation profiles of 0.65 mg/mL 
OppA*. Time intervals were 10 min. b) Average sedimentation coefficient (s20,w) 
values plotted against the OppA* concentration in the absence (filled circles) or 
presence (open circles) of a saturating concentration of bradykinin. The horizontal 
lines indicate the average s20,w values obtained in the absence (long dash) or presence 
(short dash) of ligand. c) Sedimentation equilibrium analysis. Radial distribution of 
OppA* at 10,000 rpm and 4ºC with protein loading concentrations of 0.02 (squares), 
0.05 (inverted triangles) and 0.10 mg/mL (circles) in the presence of saturating 
concentrations of bradykinin. The solid lines represent the best fit described by global 
analysis of nine datasets collected at rotor speeds of 8, 10 and 12 krpm. Residuals are 
shown in the top graph. 
Figure S2 
 
Sequence alignment of OppA of Lactococcus lactis (OppA_Ll), AppA of Bacillus 
subtilis (AppA_Bs), DppA of E. coli (DppA_Ec) and OppA of
 
 S. typhimurium 
(OppA_St), based on an alignment of the 3D structures of the proteins. The 
percentages of identical residues compared to are: AppA_Bs 20.8%, DppA_Ec 20.5% 
and OppA_St 20.5%. Arrows above sequence indicate ß-strands, spirals indicate a-
helices. Stars below the alignment indicate residues in OppA_Ll that interact with the 




Binding of bradykinin to OppA* monitored by intrinsic protein fluorescence 
measurements. Titration of OppA* (after GndHCl treatment to remove endogenous 
peptides) with bradykinin. The protein concentration was 0.5 µM. The change in 
protein fluorescence (•F) was measured and the data fitted as previously described 






Stereo view of OppA* in the closed (A) and open (B) conformation. The color 
scheme is the same as in Fig. 2
Figure S5 
 
Snapshots of peptide-protein interactions during MD simulation. Panels A-D shows 
snapshots at different time points during the simulation. Ala476 and Ser474 are at a 
distance to form hydrogen bonds with different peptide residues in all the snapshots, 
but Asp483 only in D. The register shift of the peptide at different time points is 





Ramachandran plot of the bound ligand bradykinin (RPPGFSPFR). Ramachandran 
allowed and favored regions for proline are outlined. Five residues of the bound 
peptide fit within the limits of proline. 
Table I 
Data collection and refinement statistics 
 Open conformation  Closed conformation 






peptide (16 a.a.) 
Neuropeptid 
S (20 a.a.) 












Space group P21 P21 P21 P21  P1 P212121 P212121 P212121 P212121 P212121 
Cell dimensions 
    
   




















    a, b, g (°)  90, 90, 104  90, 90, 104  90, 90, 104  90, 90, 104   90 90 90 90 90 90 
 Native Native Native Native  Native Native Peak Inflection Remote S-SAD 
Wavelength (Å) 0.934 0.931 0.931 0.931  0.933 1.12 0.9197 0.9200 0.9168 1.7753 
Resolution range 
(Å) 
40-1.7 42.3-1.8 37.1-1.5 42.1-1.8  58.2-2.5 30.4-1.3 62.7-2.0 62.3-2.5 62.3-2.5 62.3-2.5 
R
sym
 0.071 (0.392) 0.110 
(0.259) 














I/ σ  (I) 10.8 (2.0) 2.3 (2.8) 7.9 (3.2) 3.1 (2.8)  2.0 (2.7) 8.1 (1.8) 13.8 (9.6) 10.7 (4.3) 12.8 (6.2) 7.4 (4.1) 
Completeness (%) 99.7 (99.9) 100.0 
(100.0) 
95.9 (91.8) 97.3 (97.3)  96.2 (95.7) 99.8 (100) 98.1 (97.1) 97.3 (95.9) 98.0 (97.0) 99.5 (98.6) 
Redundancy 2.8 3.7 2.4 2.2  2.0 4.6 4.7 4.7 4.7 30.5 
        
Refinement            
Resolution (Å) 35.9-1.7 42.3-1.8 37.1-1.5 42.1-1.8  58.2-2.5 30.4-1.3     
Number of 
reflections 
60836 51692 85971 47251  18131 119254     
R
work/Rfree
 0.167/0.205 0.164/0.203 0.165/0.208 0.197/0.248  0.220/0.275 0.133/0.161     
No. atoms            
    Protein 4410 4359 4403 4374  4372 4349     
    Ligand/ion 30 32 34 34  69 48     
    Water 736 763 897 491  138 1111     
B-factors            
    Protein 12.7 18.1 12.8 18.9  38.9 9.9     
    Ligand/ion 26.1 30.3 29.3 27.2  37.6 13.0     
    Water 27.8 32.3 29.9 27.9  31.9 24.6     
R.m.s. deviations             
Bond lengths (Å) 0.011 0.008 0.015 0.007  0.006 0.007     
Bond angles (°) 1.276 1.103 1.562 1.026  1.143 1.269     
*The number in parentheses corresponds to the highest resolution shell        
Table II 
Identified endogenous peptides. The table lists all identified endogenous peptides with 
a confidence of >99%, with their corresponding protein.  
 
Peptide Protein 
AEVSGPIPLPTDRS 30S ribosomal protein S10 
AEVSGPIPLPTDRSVY 30S ribosomal protein S10 
VSGPIPLPTDRS 30S ribosomal protein S10 
TNAEVSGPIPLPTDR 30S ribosomal protein S10 
AEVESFQLDH 30S ribosomal protein S10 
EGISTDPYERKVI 30S ribosomal protein S10 
ISTDPYERKVI 30S ribosomal protein S10 
TNAEVSGPIPLPTDRS 30S ribosomal protein S10 
EVSGPIPLPTDRSVY 30S ribosomal protein S10 
TNAEVSGPIPLPTDRSVY 30S ribosomal protein S10 
NAEVSGPIPLPTDRSVY 30S ribosomal protein S10 
TNAEVSGPIPLPTDRSVYT 30S ribosomal protein S10 
GALDTAGVADRKQ 30S ribosomal protein S12 
GALDTAGVADRKQS 30S ribosomal protein S12 
GADIARAEGYS 30S ribosomal protein S3 
GADIARAEGYSEGTVPLHT 30S ribosomal protein S3 
IKTQVSGRLN 30S ribosomal protein S3 
AVLELAGVADVTSKSLGSNTPINVVR 30S ribosomal protein S5 
GADIARAEGYSEG 30S ribosomal protein S5 
GADIARAEGYSEGTVPLH 30S ribosomal protein S5 
QEVPEAIRKA 30S ribosomal protein S5  
SNTPINVVR 30S ribosomal protein S5  
SVTAGELREK 50S ribosomal protein L13 
ISNGVGVER 50S ribosomal protein L19 
NSGINETYTVRK 50S ribosomal protein L19 
SGINETYTVRK 50S ribosomal protein L19 
TDIPDFRPGDT 50S ribosomal protein L19 
EITTSTPEK 50S ribosomal protein L2 
GIKVYKPTTN 50S ribosomal protein L2 
GIKVYKPTTNG 50S ribosomal protein L2 
MTGSDFAEITTSTPEK 50S ribosomal protein L2 
MTGSDFAEITTSTPEKS 50S ribosomal protein L2 
MTGSDFAEITTSTPEKSL 50S ribosomal protein L2 
MTGSDFAEITTSTPEKSLLVS 50S ribosomal protein L2 
NMTGSDFAEITTSTPEK 50S ribosomal protein L2 
NMTGSDFAEITTSTPEKS 50S ribosomal protein L2 
SPMTPWGKPALG 50S ribosomal protein L2 
SVMNPNDHPHGGG 50S ribosomal protein L2 
SVMNPNDHPHGGGEG 50S ribosomal protein L2 
TIEYDPNRTAN 50S ribosomal protein L2 
VATIEYDPNRTA 50S ribosomal protein L2 
VATIEYDPNRTAN 50S ribosomal protein L2 
AIIKTGGKQ 50S ribosomal protein L21 
QVKVEEGSVIYVEK 50S ribosomal protein L21 
SNYAIIKTGGKQ 50S ribosomal protein L21 
AISEGIEVYGINHGYA 6-phosphofructokinase 
VELLRDGIGGVAVG 6-phosphofructokinase 
AFDVLDEEAGLAQR Alkyl hydroperoxide reductase subunit C 
FDVLDEEAGLAQR Alkyl hydroperoxide reductase subunit C 
DQVDVEDMGGTLR CTP synthase 
AHIDAPGHAD Elongation factor Tu (EF-Tu) 
APGHADYVKN Elongation factor Tu (EF-Tu) 
ASIDAAPEERER Elongation factor Tu (EF-Tu) 
ATDFASIDAAPEER Elongation factor Tu (EF-Tu) 
ATDFASIDAAPEERER Elongation factor Tu (EF-Tu) 
ATDGPMPQTR Elongation factor Tu (EF-Tu) 
DEIERGQVIAKPG Elongation factor Tu (EF-Tu) 
DEIERGQVIAKPGS Elongation factor Tu (EF-Tu) 
DGAILVVAATDGPMPQTR Elongation factor Tu (EF-Tu) 
DIVDEYIPTPER Elongation factor Tu (EF-Tu) 
EGGRTVGSG Elongation factor Tu (EF-Tu) 
EGLAGDNVGALLR Elongation factor Tu (EF-Tu) 
EGLAGDNVGALLRG Elongation factor Tu (EF-Tu) 
FASIDAAPEER Elongation factor Tu (EF-Tu) 
FDNYRPQ Elongation factor Tu (EF-Tu) 
FFDNYRPQ Elongation factor Tu (EF-Tu) 
GIQRDEIERGQ Elongation factor Tu (EF-Tu) 
IDAAPEER Elongation factor Tu (EF-Tu) 
IDAAPEERER Elongation factor Tu (EF-Tu) 
IDAAPEERERG Elongation factor Tu (EF-Tu) 
IEQGTTFSIR Elongation factor Tu (EF-Tu) 
IERGQVIAKPG Elongation factor Tu (EF-Tu) 
IVDEYIPTPER Elongation factor Tu (EF-Tu) 
LAGDNVGALLR Elongation factor Tu (EF-Tu) 
LPVEDVFSITGRG Elongation factor Tu (EF-Tu) 
LTEGLAGDNVGALLR Elongation factor Tu (EF-Tu) 
LTEGLAGDNVGALLRG Elongation factor Tu (EF-Tu) 
SIDAAPEERER Elongation factor Tu (EF-Tu) 
TDFASIDAAPEER Elongation factor Tu (EF-Tu) 
TDFASIDAAPEERER Elongation factor Tu (EF-Tu) 
TDFASIDAAPEERERG Elongation factor Tu (EF-Tu) 
TEGLAGDNVGALLR Elongation factor Tu (EF-Tu) 
TLTEGLAGDNVGAL Elongation factor Tu (EF-Tu) 
TLTEGLAGDNVGALLR Elongation factor Tu (EF-Tu) 
TLTEGLAGDNVGALLRG Elongation factor Tu (EF-Tu) 
TPFFDNYRPQ Elongation factor Tu (EF-Tu) 
VAIEQGTTF Elongation factor Tu (EF-Tu) 
DSNALEQER GTP-binding protein TypA/BipA homolog 
NTAVEYNGTR GTP-binding protein TypA/BipA homolog 
EVFNSFMDEQED llmg_0152 conserved hypothetical protein 
IDGQEEFGKNY llmg_0152 conserved hypothetical protein 
ITIDGQEEFGKNY llmg_0152 conserved hypothetical protein 
LVDENGNESLF llmg_0152 conserved hypothetical protein 
PTEFEEDEQG llmg_0152 conserved hypothetical protein 
VVLQPTEF llmg_0152 conserved hypothetical protein 
VVLQPTEFEEDEQG llmg_0152 conserved hypothetical protein 
GYPETDPHGSEIPTES llmg_1224 Transcriptional regulator  
AEGISTDPYERK luxS S-ribosylhomocysteinase 
AQVTKSKSPAMN luxS S-ribosylhomocysteinase 
EGISTDPYER luxS S-ribosylhomocysteinase 
EGISTDPYERK luxS S-ribosylhomocysteinase 
ILAEGISTDPYER luxS S-ribosylhomocysteinase 
VTAYIPGIGH luxS S-ribosylhomocysteinase 
VTAYIPGIGHN luxS S-ribosylhomocysteinase 
FTLSGEPAEILR ptsK Hpr kinase/phosphatase 
NAPTIVEFSDVEVPQTR ptsK Hpr kinase/phosphatase 
NAPTIVEFSDVEVPQTRIPVK ptsK Hpr kinase/phosphatase 
 
  
 
